{"protocolSection": {"identificationModule": {"nctId": "NCT00608491", "orgStudyIdInfo": {"id": "Pro00018064"}, "secondaryIdInfos": [{"id": "U01HL084904-04", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/U01HL084904-04"}, {"id": "U01HL084904", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/U01HL084904"}, {"id": "522"}], "organization": {"fullName": "Duke University", "class": "OTHER"}, "briefTitle": "Effectiveness of Ultrafiltration in Treating People With Acute Decompensated Heart Failure and Cardiorenal Syndrome (The CARRESS Study)", "officialTitle": "CARdiorenal REScue Study in Acute Decompensated Heart Failure: CARRESS", "acronym": "CARRESS"}, "statusModule": {"statusVerifiedDate": "2013-05", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-03"}, "primaryCompletionDateStruct": {"date": "2012-03", "type": "ACTUAL"}, "completionDateStruct": {"date": "2012-06", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-01-25", "studyFirstSubmitQcDate": "2008-01-25", "studyFirstPostDateStruct": {"date": "2008-02-06", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2013-02-18", "resultsFirstSubmitQcDate": "2013-05-15", "resultsFirstPostDateStruct": {"date": "2013-06-24", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2013-05-15", "lastUpdatePostDateStruct": {"date": "2013-06-24", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Duke University", "class": "OTHER"}, "collaborators": [{"name": "National Heart, Lung, and Blood Institute (NHLBI)", "class": "NIH"}, {"name": "Nuwellis, Inc.", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "Heart failure is a serious condition in which the heart's ability to pump blood through the body is impaired, often making a person feel weak or fatigued. When a person's condition worsens to the point of hospitalization, that person is said to have acute decompensated heart failure (ADHF). Abnormal kidney function in association with cardiac distress, known as cardiorenal syndrome, is a common complication of heart failure and causes further medical problems and need for hospitalization. While there are various effective treatments for heart failure, more research is needed to determine the best treatment for targeting both ADHF and cardiorenal syndrome. This study will compare the safety and effectiveness of ultrafiltration versus standard medical drug therapy in improving renal function and relieving fluid buildup in people hospitalized with ADHF and cardiorenal syndrome.", "detailedDescription": "Heart failure is a common condition that affects approximately 5 million people in the United States, with 550,000 new cases diagnosed each year. Common symptoms of heart failure include swelling and fluid buildup in the legs, feet, and/or lungs; shortness of breath; coughing; elevated heart rate; change in appetite; and fatigue. If left untreated, the condition of the heart may deteriorate so far that the person undergoes ADHF. The number of hospitalizations attributed to ADHF has risen significantly, with many people readmitted soon after discharge because of recurring symptoms or further medical complications, such as cardiorenal syndrome. Current heart failure treatments focus on removing excess fluid buildup, often by increasing urination with diuretic medications or by draining directly from the veins. Direct drainage from the veins, also known as ultrafiltration, may be the more effective method for treating people with ADHF and cardiorenal syndrome. This study will compare the safety and effectiveness of ultrafiltration versus standard medical drug therapy in improving renal function and relieving fluid buildup in people hospitalized with ADHF and cardiorenal syndrome.\n\nParticipation in this study will last 60 days. All potential participants will undergo initial screening, which will include a medical history, physical exam, blood draws, measurements of fluid intake and urine output, and questionnaires. These same evaluations and procedures will be repeated at various points during the hospital stay. Eligible participants will be randomly assigned to receive standard medical drug therapy or fluid removal by ultrafiltration. Standard medical drug therapy will involve the intravenous delivery of diuretics and possibly other doctor-recommended medications. Ultrafiltration will involve intravenously removing blood, passing it through an ultrafiltration device, and then returning the blood to the participant. During ultrafiltration, participants will be treated with a blood thinner through the IV, as well.\n\nFollow-up assessments will occur at Days 30 and 60 after treatment. Follow-up assessments will include measurements of fluid intake, urine output, and vital signs; blood draws; physical exams; and questions about medications and status of recovery."}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["Acute Decompensated Heart Failure", "Acute Decompensated Heart Failure With Cardiorenal Syndrome", "Cardiorenal Syndrome", "Persistent Congestion", "Ultra Filtration"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 188, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Stepped pharmacologic care", "type": "ACTIVE_COMPARATOR", "description": "Stepped care will provide treating physicians with guidelines for the intensification of diuretic therapy and the possible use of vasodilators and inotropes.", "interventionNames": ["Drug: Stepped pharmacologic care"]}, {"label": "Ultrafiltration", "type": "EXPERIMENTAL", "description": "All loop diuretics will be discontinued. Treatment will involve slow continuous ultrafiltration until an optimal volume status has been achieved. Ultrafiltration therapy will be initiated after the placement of appropriate intravenous access and will continue until the participant's signs and symptoms of congestion have been optimized. Fluid status will be managed exclusively by ultrafiltration using the Aquadex system 100 (CHF Solutions, Inc.) according to the manufacturer's specifications. The use of vasodilators or inotropic agents will be prohibited unless deemed necessary for rescue therapy.", "interventionNames": ["Device: Ultrafiltration"]}], "interventions": [{"type": "DRUG", "name": "Stepped pharmacologic care", "description": "Stepped care will provide treating physicians with guidelines for the intensification of diuretic therapy and the possible use of vasodilators and inotropes.", "armGroupLabels": ["Stepped pharmacologic care"]}, {"type": "DEVICE", "name": "Ultrafiltration", "description": "All loop diuretics will be discontinued. Treatment will involve slow continuous ultrafiltration until an optimal volume status has been achieved. Ultrafiltration therapy will be initiated after the placement of appropriate intravenous access and will continue until the participant's signs and symptoms of congestion have been optimized. Fluid status will be managed exclusively by ultrafiltration using the Aquadex system 100 (CHF Solutions, Inc.) according to the manufacturer's specifications. The use of vasodilators or inotropic agents will be prohibited unless deemed necessary for rescue therapy.", "armGroupLabels": ["Ultrafiltration"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change in Serum Creatinine", "timeFrame": "Change from Baseline to Day 4"}, {"measure": "Change in Weight", "timeFrame": "Change from Baseline to Day 4"}], "secondaryOutcomes": [{"measure": "Change in Glomerular Filtration Rate", "timeFrame": "Change from Baseline to Day 4"}, {"measure": "Change in Serum Creatinine", "timeFrame": "Change from Baseline to Day 7"}, {"measure": "Change in Glomerular Filtration Rate", "timeFrame": "Change from Baseline to Day 7"}, {"measure": "Changes in Weight", "timeFrame": "Change from Baseline to Day 1"}, {"measure": "Changes in Weight", "timeFrame": "Change from Baseline to Day 2"}, {"measure": "Change in Weight", "timeFrame": "Change from Baseline to Day 3"}, {"measure": "Changes in Weight", "timeFrame": "Change from Baseline to Day 5"}, {"measure": "Change in Weight", "timeFrame": "Change from Baseline to Day 6"}, {"measure": "Cumulative Net Fluid Loss", "timeFrame": "Randomization through Day 1"}, {"measure": "Cumulative Net Fluid Loss", "timeFrame": "Randomization through Day 2"}, {"measure": "Cumulative Net Fluid Loss", "timeFrame": "Randomization through Day 3"}, {"measure": "Cumulative Net Fluid Loss", "timeFrame": "Randomization through Day 4"}, {"measure": "Cumulative Net Fluid Loss", "timeFrame": "Randomization through Day 5"}, {"measure": "Cumulative Net Fluid Loss", "timeFrame": "Randomization through Day 6"}, {"measure": "Cumulative Net Fluid Loss", "timeFrame": "Randomization through Day 7"}, {"measure": "Dyspnea Visual Analog Scale", "description": "Scale range: -100 , +100\n\n-100=worse, +100=better", "timeFrame": "Change from Baseline to Day 4"}, {"measure": "Change in Global Visual Analog Scale", "description": "Scale range: -100 , +100\n\n-100=worse, +100=better Participants asked to mark their global well being on a 10 cm vertical line, with the top labeled \"best you have ever felt\" and the bottom labeled \"worst you have ever felt\".", "timeFrame": "Change from Baseline to Day 4"}, {"measure": "Change in Dyspnea Visual Analog Scale", "description": "Scale range: -100 , +100\n\n-100=worse, +100=better", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Global Visual Analog Scale", "description": "Scale range: -100 , +100\n\n-100=worse, +100=better Participants asked to mark their global well being on a 10 cm vertical line, with the top labeled \"best you have ever felt\" and the bottom labeled \"worst you have ever felt\".", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Furosemide-Equivalent Dose", "description": "Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40)", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Sodium Level", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Potassium Level", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Urea Nitrogen/Urea", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Bicarbonate Level", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Hemoglobin Level", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Sodium Level", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Potassium Level", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Urea Nitrogen/Urea", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Bicarbonate Level", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Hemoglobin Level", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Cystatin C", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Uric Acid", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood N- Terminal Pro- BNP", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Plasma Renin Activity", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood High Sensitivity Troponin I", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Aldosterone", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Procollagen III N-terminal Propepide", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Endothelin-1", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood High Sensitivity C-Reactive Protein", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Carboxy-terminal Telopeptide of Collagen Type I", "timeFrame": "Baseline to Day 4"}, {"measure": "Change in Blood Cystatin C", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Uric Acid", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood N Terminal Pro-Natriuretic Peptide", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Plasma Renin Activity", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood High Sensitivity Troponin I", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Aldosterone", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Procollagen III N-terminal Propepide", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Endothelin-1", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood Carboxy-terminal Telopeptide of Collagen Type I", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Change in Blood High Sensitivity C-Reactive Protein", "timeFrame": "Baseline to Day 7/Discharge"}, {"measure": "Weight Change", "timeFrame": "Baseline to Day 30"}, {"measure": "Change in Furosemide-Equivalent Dose", "description": "Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40)", "timeFrame": "Baseline to Day 30"}, {"measure": "Creatinine Change", "timeFrame": "Baseline to Day 30"}, {"measure": "Glomerular Filtration Rate Change", "timeFrame": "Baseline to Day 30"}, {"measure": "Weight Change", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Furosemide-Equivalent Dose", "description": "Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40)", "timeFrame": "Baseline to Day 60"}, {"measure": "Best Available Serum Creatinine Change", "description": "Core laboratory when available. If not available, local laboratory results were used.", "timeFrame": "Baseline to Day 60"}, {"measure": "Best Available Glomerular Filtration Rate Change", "description": "Core laboratory when available. If not available, local laboratory results were used.", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood Uric Acid", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood Cystatin C", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood N Terminal Pro - B Natriuretic Peptides", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Plasma Renin Activity", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood High Sensitivity Troponin I", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood Aldosterone", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood Procollagen III N-terminal Propepide", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood Endothelin-1", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood High Sensitivity C-Reactive Protein", "timeFrame": "Baseline to Day 60"}, {"measure": "Change in Blood Carboxy-terminal Telopeptide of Collagen Type I", "timeFrame": "Baseline to Day 60"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion criteria:\n\n* age 18 or older\n* admitted to the hospital with a primary diagnosis of decompensated heart failure\n* onset of cardiorenal syndrome after hospitalization or pre-hospitalization\n* after hospitalization - onset of cardiorenal syndrome after hospitalization must occur within 10 days from the time of admission after receiving IV diuretics\n* pre-hospitalization - onset of cardiorenal syndrome pre-hospitalization must occur within 12 weeks of the index hospitalization in the setting of escalating doses of outpatient diuretics\n* persistent volume overload\n\nExclusion criteria:\n\n* intravascular volume depletion based on investigator\"s clinical assessment\n* acute coronary syndrome within 4 weeks\n* indication for hemodialysis\n* creatinine \\> 3.5 mg per deciliter at admission to the hospital\n* systolic blood pressure \\< 90 mmHg at the time of enrollment\n* alternative explanation for worsening renal function such as obstructive nephropathy,contrast induced nephropathy, acute tubular necrosis\n* Hematocrit \\> 45%\n* poor venous access\n* clinical instability likely to require the addition of intravenous vasoactive drugs including vasodilators and/or inotropic agents\n* allergy or contraindications to the use of heparin\n* the use of iodinated radio contrast material in the last 72 hours or anticipated use of IV contrast during the current hospitalization\n* known bilateral renal artery stenosis\n* active myocarditis\n* hypertrophic obstructive cardiomyopathy\n* severe valvular stenosis\n* complex congenital heart disease\n* sepsis or ongoing systemic infection\n* enrollment in another clinical trial involving medical or device based interventions", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Kerry L. Lee, PhD", "affiliation": "Duke Clinical Research Institute", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Mayo Clinic Arizona", "city": "Phoenix", "state": "Arizona", "zip": "85054", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "Morehouse School of Medicine", "city": "Atlanta", "state": "Georgia", "zip": "30310", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Minnesota Heart Failure Network", "city": "Minneapolis", "state": "Minnesota", "zip": "55415", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "Mayo Clinic", "city": "Rochester", "state": "Minnesota", "zip": "55905", "country": "United States", "geoPoint": {"lat": 44.02163, "lon": -92.4699}}, {"facility": "Duke University Medical Center", "city": "Durham", "state": "North Carolina", "zip": "27705", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "Baylor College of Medicine", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "University of Utah Health Sciences Center", "city": "Murray", "state": "Utah", "zip": "84107", "country": "United States", "geoPoint": {"lat": 40.66689, "lon": -111.88799}}, {"facility": "University of Vermont - Fletcher Allen Health Care", "city": "Burlington", "state": "Vermont", "zip": "05401", "country": "United States", "geoPoint": {"lat": 44.47588, "lon": -73.21207}}, {"facility": "Montreal Heart Institute", "city": "Montreal", "state": "Quebec", "zip": "H1T - 1C8", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}]}, "referencesModule": {"references": [{"pmid": "23131078", "type": "RESULT", "citation": "Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E; Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012 Dec 13;367(24):2296-304. doi: 10.1056/NEJMoa1210357. Epub 2012 Nov 6."}, {"pmid": "31163974", "type": "DERIVED", "citation": "Rao VS, Ahmad T, Brisco-Bacik MA, Bonventre JV, Wilson FP, Siew ED, Felker GM, Anstrom KK, Mahoney DD, Bart BA, Tang WHW, Velazquez EJ, Testani JM. Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function. Circ Heart Fail. 2019 Jun;12(6):e005552. doi: 10.1161/CIRCHEARTFAILURE.118.005552. Epub 2019 Jun 5."}, {"pmid": "28130379", "type": "DERIVED", "citation": "Kitai T, Grodin JL, Kim YH, Tang WH. Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function. Circ Heart Fail. 2017 Feb;10(2):e003603. doi: 10.1161/CIRCHEARTFAILURE.116.003603. Erratum In: Circ Heart Fail. 2017 Mar;10 (3):e000016."}, {"pmid": "26927285", "type": "DERIVED", "citation": "de Denus S, Rouleau JL, Mann DL, Huggins GS, Cappola TP, Shah SH, Keleti J, Zada YF, Provost S, Bardhadi A, Phillips MS, Normand V, Mongrain I, Dube MP. A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. Pharmacogenomics J. 2017 Mar;17(2):192-200. doi: 10.1038/tpj.2016.4. Epub 2016 Mar 1."}, {"pmid": "26041600", "type": "DERIVED", "citation": "Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, DeVore AD, Khazanie P, Redfield MM, Goldsmith SR, Bart BA, Anstrom KJ, Felker GM, Hernandez AF, Stevenson LW. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail. 2015 Jul;8(4):741-8. doi: 10.1161/CIRCHEARTFAILURE.114.001957. Epub 2015 Jun 3."}, {"pmid": "25543972", "type": "DERIVED", "citation": "Mentz RJ, Stevens SR, DeVore AD, Lala A, Vader JM, AbouEzzeddine OF, Khazanie P, Redfield MM, Stevenson LW, O'Connor CM, Goldsmith SR, Bart BA, Anstrom KJ, Hernandez AF, Braunwald E, Felker GM. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. JACC Heart Fail. 2015 Feb;3(2):97-107. doi: 10.1016/j.jchf.2014.09.003. Epub 2014 Oct 31."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Stepped Pharmacologic Care", "description": "Stepped care will provide treating physicians with guidelines for the intensification of diuretic therapy and the possible use of vasodilators and inotropes"}, {"id": "FG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "94"}, {"groupId": "FG001", "numSubjects": "94"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "73"}, {"groupId": "FG001", "numSubjects": "72"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "21"}, {"groupId": "FG001", "numSubjects": "22"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "BG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "94"}, {"groupId": "BG001", "value": "94"}, {"groupId": "BG002", "value": "188"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "42"}, {"groupId": "BG001", "value": "35"}, {"groupId": "BG002", "value": "77"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "52"}, {"groupId": "BG001", "value": "59"}, {"groupId": "BG002", "value": "111"}]}]}]}, {"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "67.1", "spread": "13.7"}, {"groupId": "BG001", "value": "68.9", "spread": "12.0"}, {"groupId": "BG002", "value": "68.0", "spread": "12.9"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "21"}, {"groupId": "BG002", "value": "47"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "68"}, {"groupId": "BG001", "value": "73"}, {"groupId": "BG002", "value": "141"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change in Serum Creatinine", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Change from Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "spread": "0.53"}, {"groupId": "OG001", "value": "0.23", "spread": "0.70"}]}]}]}, {"type": "SECONDARY", "title": "Change in Glomerular Filtration Rate", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL/min", "timeFrame": "Change from Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.67", "spread": "10.94"}, {"groupId": "OG001", "value": "0.93", "spread": "14.60"}]}]}]}, {"type": "SECONDARY", "title": "Change in Serum Creatinine", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Change from Baseline to Day 7", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.00", "spread": "0.60"}, {"groupId": "OG001", "value": "0.11", "spread": "0.89"}]}]}]}, {"type": "SECONDARY", "title": "Change in Glomerular Filtration Rate", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL/min", "timeFrame": "Change from Baseline to Day 7", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.06", "spread": "9.32"}, {"groupId": "OG001", "value": "1.82", "spread": "13.84"}]}]}]}, {"type": "SECONDARY", "title": "Changes in Weight", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "lbs", "timeFrame": "Change from Baseline to Day 1", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "90"}, {"groupId": "OG001", "value": "88"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-3.4", "spread": "5.2"}, {"groupId": "OG001", "value": "-4.4", "spread": "4.5"}]}]}]}, {"type": "SECONDARY", "title": "Changes in Weight", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "lbs", "timeFrame": "Change from Baseline to Day 2", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "91"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-7.4", "spread": "8.6"}, {"groupId": "OG001", "value": "-8.8", "spread": "7.4"}]}]}]}, {"type": "SECONDARY", "title": "Change in Weight", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "lbs", "timeFrame": "Change from Baseline to Day 3", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}, {"groupId": "OG001", "value": "86"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-10.8", "spread": "10.5"}, {"groupId": "OG001", "value": "-11.7", "spread": "7.7"}]}]}]}, {"type": "SECONDARY", "title": "Changes in Weight", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "lbs", "timeFrame": "Change from Baseline to Day 5", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "62"}, {"groupId": "OG001", "value": "69"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-15.6", "spread": "12.0"}, {"groupId": "OG001", "value": "-14.3", "spread": "10.0"}]}]}]}, {"type": "SECONDARY", "title": "Change in Weight", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "lbs", "timeFrame": "Change from Baseline to Day 6", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "59"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-16.5", "spread": "15.3"}, {"groupId": "OG001", "value": "-15.7", "spread": "11.8"}]}]}]}, {"type": "SECONDARY", "title": "Cumulative Net Fluid Loss", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Randomization through Day 1", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1714.1", "spread": "1400.2"}, {"groupId": "OG001", "value": "2193.6", "spread": "1554.9"}]}]}]}, {"type": "SECONDARY", "title": "Cumulative Net Fluid Loss", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Randomization through Day 2", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "92"}, {"groupId": "OG001", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3814.2", "spread": "2384.2"}, {"groupId": "OG001", "value": "4705.8", "spread": "2626.9"}]}]}]}, {"type": "PRIMARY", "title": "Change in Weight", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "lbs", "timeFrame": "Change from Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-12.1", "spread": "11.3"}, {"groupId": "OG001", "value": "-12.6", "spread": "8.5"}]}]}]}, {"type": "SECONDARY", "title": "Cumulative Net Fluid Loss", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Randomization through Day 3", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}, {"groupId": "OG001", "value": "90"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5706.8", "spread": "3490.6"}, {"groupId": "OG001", "value": "6257.1", "spread": "3519.7"}]}]}]}, {"type": "SECONDARY", "title": "Cumulative Net Fluid Loss", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Randomization through Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "79"}, {"groupId": "OG001", "value": "81"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7081.5", "spread": "4183.4"}, {"groupId": "OG001", "value": "7443.0", "spread": "4328.7"}]}]}]}, {"type": "SECONDARY", "title": "Cumulative Net Fluid Loss", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Randomization through Day 5", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "63"}, {"groupId": "OG001", "value": "69"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "8358.8", "spread": "5034.5"}, {"groupId": "OG001", "value": "8308.4", "spread": "5178.1"}]}]}]}, {"type": "SECONDARY", "title": "Cumulative Net Fluid Loss", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Randomization through Day 6", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "9700.7", "spread": "6945.9"}, {"groupId": "OG001", "value": "9822.1", "spread": "6001.7"}]}]}]}, {"type": "SECONDARY", "title": "Cumulative Net Fluid Loss", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Randomization through Day 7", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "40"}, {"groupId": "OG001", "value": "47"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "11659.6", "spread": "9142.0"}, {"groupId": "OG001", "value": "10595.1", "spread": "7097.4"}]}]}]}, {"type": "SECONDARY", "title": "Dyspnea Visual Analog Scale", "description": "Scale range: -100 , +100\n\n-100=worse, +100=better", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "Change from Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "20.5", "spread": "27.8"}, {"groupId": "OG001", "value": "16.5", "spread": "29.2"}]}]}]}, {"type": "SECONDARY", "title": "Change in Global Visual Analog Scale", "description": "Scale range: -100 , +100\n\n-100=worse, +100=better Participants asked to mark their global well being on a 10 cm vertical line, with the top labeled \"best you have ever felt\" and the bottom labeled \"worst you have ever felt\".", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "Change from Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "87"}, {"groupId": "OG001", "value": "81"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "22.8", "spread": "25.8"}, {"groupId": "OG001", "value": "13.7", "spread": "27.9"}]}]}]}, {"type": "SECONDARY", "title": "Change in Dyspnea Visual Analog Scale", "description": "Scale range: -100 , +100\n\n-100=worse, +100=better", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "88"}, {"groupId": "OG001", "value": "86"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "22.8", "spread": "27.6"}, {"groupId": "OG001", "value": "19.4", "spread": "31.4"}]}]}]}, {"type": "SECONDARY", "title": "Change in Global Visual Analog Scale", "description": "Scale range: -100 , +100\n\n-100=worse, +100=better Participants asked to mark their global well being on a 10 cm vertical line, with the top labeled \"best you have ever felt\" and the bottom labeled \"worst you have ever felt\".", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "87"}, {"groupId": "OG001", "value": "86"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "25.8", "spread": "30.2"}, {"groupId": "OG001", "value": "16.9", "spread": "29.0"}]}]}]}, {"type": "SECONDARY", "title": "Change in Furosemide-Equivalent Dose", "description": "Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40)", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "92"}, {"groupId": "OG001", "value": "89"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.2", "spread": "166.5"}, {"groupId": "OG001", "value": "-20.6", "spread": "116.0"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Sodium Level", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mEq/L", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.00", "spread": "3.60"}, {"groupId": "OG001", "value": "-2.3", "spread": "3.51"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Potassium Level", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mEq/L", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.23", "spread": "0.63"}, {"groupId": "OG001", "value": "0.26", "spread": "0.70"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Urea Nitrogen/Urea", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.68", "spread": "18.29"}, {"groupId": "OG001", "value": "12.54", "spread": "24.81"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Bicarbonate Level", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mEq/L", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}, {"groupId": "OG001", "value": "84"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.29", "spread": "3.82"}, {"groupId": "OG001", "value": "-1.01", "spread": "4.17"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Hemoglobin Level", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "g/dL", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}, {"groupId": "OG001", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.38", "spread": "0.76"}, {"groupId": "OG001", "value": "-0.01", "spread": "0.92"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Sodium Level", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mEq/L", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.49", "spread": "3.70"}, {"groupId": "OG001", "value": "-2.02", "spread": "4.11"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Potassium Level", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mEq/L", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "92"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.14", "spread": "0.60"}, {"groupId": "OG001", "value": "0.27", "spread": "0.75"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Urea Nitrogen/Urea", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "94"}, {"groupId": "OG001", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7.23", "spread": "20.69"}, {"groupId": "OG001", "value": "13.81", "spread": "23.91"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Bicarbonate Level", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mEq/L", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}, {"groupId": "OG001", "value": "84"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.07", "spread": "4.50"}, {"groupId": "OG001", "value": "-0.70", "spread": "5.03"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Hemoglobin Level", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "g/dL", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "89"}, {"groupId": "OG001", "value": "93"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.35", "spread": "0.94"}, {"groupId": "OG001", "value": "-0.02", "spread": "0.96"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Cystatin C", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/L", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "81"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.14", "spread": "0.52"}, {"groupId": "OG001", "value": "0.22", "spread": "0.52"}]}]}]}, {"type": "SECONDARY", "title": "Change in Uric Acid", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "80"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.06", "spread": "1.44"}, {"groupId": "OG001", "value": "-0.23", "spread": "1.67"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood N- Terminal Pro- BNP", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "84"}, {"groupId": "OG001", "value": "79"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-978.61", "spread": "2902.06"}, {"groupId": "OG001", "value": "-814.45", "spread": "9238.91"}]}]}]}, {"type": "SECONDARY", "title": "Change in Plasma Renin Activity", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ng/mL/hr", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "81"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.78", "spread": "45.65"}, {"groupId": "OG001", "value": "12.67", "spread": "31.32"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood High Sensitivity Troponin I", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "84"}, {"groupId": "OG001", "value": "81"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "47.38", "spread": "369.85"}, {"groupId": "OG001", "value": "-38.95", "spread": "1027.37"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Aldosterone", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "81"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-109.13", "spread": "489.50"}, {"groupId": "OG001", "value": "-3.07", "spread": "485.40"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Procollagen III N-terminal Propepide", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ug/L", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "81"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.22", "spread": "4.69"}, {"groupId": "OG001", "value": "-0.64", "spread": "4.02"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Endothelin-1", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "83"}, {"groupId": "OG001", "value": "78"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.76", "spread": "1.70"}, {"groupId": "OG001", "value": "-1.13", "spread": "3.20"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood High Sensitivity C-Reactive Protein", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/L", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "81"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1.71", "spread": "46.14"}, {"groupId": "OG001", "value": "1.89", "spread": "28.60"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Carboxy-terminal Telopeptide of Collagen Type I", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ug/L", "timeFrame": "Baseline to Day 4", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "83"}, {"groupId": "OG001", "value": "76"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7.63", "spread": "11.93"}, {"groupId": "OG001", "value": "9.07", "spread": "13.46"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Cystatin C", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/L", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.12", "spread": "0.48"}, {"groupId": "OG001", "value": "0.09", "spread": "0.66"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Uric Acid", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "82"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.10", "spread": "1.85"}, {"groupId": "OG001", "value": "-0.15", "spread": "2.07"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood N Terminal Pro-Natriuretic Peptide", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1071.88", "spread": "3309.45"}, {"groupId": "OG001", "value": "-740.82", "spread": "8604.86"}]}]}]}, {"type": "SECONDARY", "title": "Change in Plasma Renin Activity", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ng/mL/hr", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.58", "spread": "40.70"}, {"groupId": "OG001", "value": "11.40", "spread": "32.75"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood High Sensitivity Troponin I", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "37.28", "spread": "350.45"}, {"groupId": "OG001", "value": "-37.16", "spread": "1231.12"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Aldosterone", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "87"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-74.26", "spread": "507.96"}, {"groupId": "OG001", "value": "68.13", "spread": "624.35"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Procollagen III N-terminal Propepide", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ug/L", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "87"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.07", "spread": "5.90"}, {"groupId": "OG001", "value": "-0.93", "spread": "3.54"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Endothelin-1", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.69", "spread": "1.85"}, {"groupId": "OG001", "value": "-1.24", "spread": "3.22"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Carboxy-terminal Telopeptide of Collagen Type I", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ug/L", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "85"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "10.21", "spread": "15.79"}, {"groupId": "OG001", "value": "10.54", "spread": "15.04"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood High Sensitivity C-Reactive Protein", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/L", "timeFrame": "Baseline to Day 7/Discharge", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "83"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-6.39", "spread": "48.56"}, {"groupId": "OG001", "value": "2.18", "spread": "37.72"}]}]}]}, {"type": "SECONDARY", "title": "Weight Change", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "lbs", "timeFrame": "Baseline to Day 30", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "73"}, {"groupId": "OG001", "value": "68"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-15.9", "spread": "22.4"}, {"groupId": "OG001", "value": "-13.4", "spread": "21.0"}]}]}]}, {"type": "SECONDARY", "title": "Change in Furosemide-Equivalent Dose", "description": "Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40)", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "Baseline to Day 30", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "78"}, {"groupId": "OG001", "value": "74"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "9.8", "spread": "188.3"}, {"groupId": "OG001", "value": "27.3", "spread": "120.1"}]}]}]}, {"type": "SECONDARY", "title": "Creatinine Change", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline to Day 30", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "75"}, {"groupId": "OG001", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.25", "spread": "0.68"}, {"groupId": "OG001", "value": "-0.12", "spread": "0.59"}]}]}]}, {"type": "SECONDARY", "title": "Glomerular Filtration Rate Change", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL/min", "timeFrame": "Baseline to Day 30", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "75"}, {"groupId": "OG001", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7.95", "spread": "11.85"}, {"groupId": "OG001", "value": "6.07", "spread": "16.13"}]}]}]}, {"type": "SECONDARY", "title": "Weight Change", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "lbs", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "66"}, {"groupId": "OG001", "value": "63"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-17.2", "spread": "21.1"}, {"groupId": "OG001", "value": "-15.4", "spread": "23.1"}]}]}]}, {"type": "SECONDARY", "title": "Change in Furosemide-Equivalent Dose", "description": "Furosemide-Equivalent Dose is the dose bumetanide or torsemide converted to furosemide equivalent (Torsemide dose x 2,Bumetanide dose x 40)", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "73"}, {"groupId": "OG001", "value": "72"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-12.4", "spread": "122.5"}, {"groupId": "OG001", "value": "8.8", "spread": "128.5"}]}]}]}, {"type": "SECONDARY", "title": "Best Available Serum Creatinine Change", "description": "Core laboratory when available. If not available, local laboratory results were used.", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "67"}, {"groupId": "OG001", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.28", "spread": "0.61"}, {"groupId": "OG001", "value": "-0.12", "spread": "0.67"}]}]}]}, {"type": "SECONDARY", "title": "Best Available Glomerular Filtration Rate Change", "description": "Core laboratory when available. If not available, local laboratory results were used.", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL/min", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "67"}, {"groupId": "OG001", "value": "70"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "8.86", "spread": "13.26"}, {"groupId": "OG001", "value": "5.63", "spread": "16.49"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Uric Acid", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "54"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.31", "spread": "2.28"}, {"groupId": "OG001", "value": "-0.54", "spread": "2.60"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Cystatin C", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/L", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.18", "spread": "0.48"}, {"groupId": "OG001", "value": "-0.03", "spread": "0.60"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood N Terminal Pro - B Natriuretic Peptides", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-490.56", "spread": "5638.86"}, {"groupId": "OG001", "value": "-937.69", "spread": "7389.14"}]}]}]}, {"type": "SECONDARY", "title": "Change in Plasma Renin Activity", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ng/mL/hr", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2.18", "spread": "41.12"}, {"groupId": "OG001", "value": "0.54", "spread": "20.48"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood High Sensitivity Troponin I", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-17.48", "spread": "106.70"}, {"groupId": "OG001", "value": "-73.58", "spread": "511.98"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Aldosterone", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "57"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-6.91", "spread": "672.21"}, {"groupId": "OG001", "value": "40.35", "spread": "471.50"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Procollagen III N-terminal Propepide", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ug/L", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "57"}, {"groupId": "OG001", "value": "56"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.75", "spread": "5.25"}, {"groupId": "OG001", "value": "0.58", "spread": "6.02"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Endothelin-1", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.82", "spread": "1.58"}, {"groupId": "OG001", "value": "-1.32", "spread": "3.98"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood High Sensitivity C-Reactive Protein", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/L", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-13.62", "spread": "59.58"}, {"groupId": "OG001", "value": "1.99", "spread": "44.92"}]}]}]}, {"type": "SECONDARY", "title": "Change in Blood Carboxy-terminal Telopeptide of Collagen Type I", "populationDescription": "Participants analyzed consisted of those participants who had the endpoint data available to be derived.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ug/L", "timeFrame": "Baseline to Day 60", "groups": [{"id": "OG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care"}, {"id": "OG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "55"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.24", "spread": "13.44"}, {"groupId": "OG001", "value": "4.57", "spread": "27.84"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Stepped Pharmacologic Care", "description": "Participants will receive stepped pharmacologic care", "seriousNumAffected": 54, "seriousNumAtRisk": 94, "otherNumAffected": 0, "otherNumAtRisk": 94}, {"id": "EG001", "title": "Ultrafiltration", "description": "Participants will receive ultrafiltration", "seriousNumAffected": 68, "seriousNumAtRisk": 94, "otherNumAffected": 0, "otherNumAtRisk": 94}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 94}]}, {"term": "Heparin-Induced Thrombocytopenia", "organSystem": "Blood and lymphatic system disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}, {"term": "Thrombocytopenia", "organSystem": "Blood and lymphatic system disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}, {"term": "Acute Coronary Syndrome", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}, {"term": "Acute Myocardial Infarction", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}, {"term": "Angina Pectoris", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}, {"term": "Atrial Fibrillation", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 94}]}, {"term": "Cardiac Failure", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 17, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 16, "numAtRisk": 94}]}, {"term": "Cardiac Failure Acute", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 94}]}, {"term": "Cardiac Failure Chronic", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 94}]}, {"term": "Pulseless Electrical Activity", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 94}]}, {"term": "Sinus Tachycardia", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}, {"term": "Ventricular Fibrillation", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 94}]}, {"term": "Ventricular Tachycardia", "organSystem": "Cardiac disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 94}]}, {"term": "Haematuria", "organSystem": "Renal and urinary disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 94}]}, {"term": "Renal Failure", "organSystem": "Renal and urinary disorders", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 94}]}, {"term": "Renal Failure Acute", "organSystem": "Renal and urinary disorders", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 94}]}, {"term": "Renal Failure Chronic", "organSystem": "Renal and urinary disorders", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 94}]}, {"term": "Renal Impairment", "organSystem": "Renal and urinary disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}, {"term": "Renal Tubular Necrosis", "organSystem": "Renal and urinary disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}, {"term": "Urinary Tract Obstruction", "organSystem": "Renal and urinary disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 94}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 94}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Jenny Ibarra", "organization": "Duke University", "email": "jenny.ibarra@duke.edu", "phone": "9192363291"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000059347", "term": "Cardio-Renal Syndrome"}, {"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000051437", "term": "Renal Insufficiency"}, {"id": "D000007674", "term": "Kidney Diseases"}, {"id": "D000014570", "term": "Urologic Diseases"}, {"id": "D000052776", "term": "Female Urogenital Diseases"}, {"id": "D000005261", "term": "Female Urogenital Diseases and Pregnancy Complications"}, {"id": "D000091642", "term": "Urogenital Diseases"}, {"id": "D000052801", "term": "Male Urogenital Diseases"}], "browseLeaves": [{"id": "M16355", "name": "Syndrome", "relevance": "LOW"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M29439", "name": "Cardio-Renal Syndrome", "asFound": "Cardiorenal Syndrome", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M26718", "name": "Renal Insufficiency", "relevance": "LOW"}, {"id": "M10698", "name": "Kidney Diseases", "relevance": "LOW"}, {"id": "M17319", "name": "Urologic Diseases", "relevance": "LOW"}, {"id": "M2875", "name": "Urogenital Diseases", "relevance": "LOW"}, {"id": "M27093", "name": "Female Urogenital Diseases", "relevance": "LOW"}, {"id": "M14127", "name": "Pregnancy Complications", "relevance": "LOW"}, {"id": "M8399", "name": "Female Urogenital Diseases and Pregnancy Complications", "relevance": "LOW"}, {"id": "M27095", "name": "Male Urogenital Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "BXS", "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"browseLeaves": [{"id": "M21860", "name": "Pharmaceutical Solutions", "relevance": "LOW"}, {"id": "M7411", "name": "Diuretics", "relevance": "LOW"}, {"id": "M17412", "name": "Vasodilator Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "PhSol", "name": "Pharmaceutical Solutions"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "VaDiAg", "name": "Vasodilator Agents"}]}}, "hasResults": true}